Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What Is the Growth Rate of the Synthetic Hormones Market?

The market size of synthetic hormones has seen robust growth in the past few years. The market is projected to expand from $6.38 billion in 2024 to $6.77 billion in 2025, experiencing a compound annual growth rate (CAGR) of 6.2%. This growth during the historic period can be traced back to factors such as animal growth promotion, performance enhancement, impact of environment, fertility treatments, and management of menopausal symptoms.

What Growth Rate Is Forecasted for the Synthetic Hormones Market by 2029?

Over the coming years, the market size for synthetic hormones is projected to witness consistent growth. By 2029, it is estimated to reach $8.15 billion, with a compound annual growth rate (CAGR) of 4.7%. The anticipated growth during this period can be ascribed to the augmentation of the transgender healthcare sphere, increased healthcare spending and insurance coverage, regulatory approvals, and broadened usage of synthetic hormones. Key trends to look out for during this forecast period include the emergence of plant-based hormone therapy, the incorporation of hormone therapy into anti-aging treatments, advances in drug delivery technology, and a focus on hormone-free birth control.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=14515&type=smp

Which Key Companies Are Shaping the Future of the Synthetic Hormones Market?

Major companies operating in the synthetic hormones market are Pfizer Inc., Johnson & Johnson, AbbVie Inc., Bristol Myers Squibb Company, Sanofi SA, AstraZeneca PLC, Novartis AG, GlaxoSmithKline PLC, Gilead Sciences Inc., Boehringer Ingelheim International GmbH, Novo Nordisk A/S, Merck & Co. Inc., Teva Pharmaceutical Industries Ltd., Ferring B.V., Endo Pharmaceuticals Inc., Lupin Pharmaceuticals Inc., IBSA Institute Biochimique SA, American Regent Inc., McGuff Pharmaceuticals Inc., Anhui Anke Biotechnology Co.Ltd., Lyndra Therapeutics Inc., Acerus Pharmaceuticals Corporation, Arch BioPartners Inc., Slayback Pharma LLC

Which Factors Are Driving Demand in the Synthetic Hormones Industry?

The synthetic hormones market’s growth is anticipated to be fueled by the rising prevalence of hormonal imbalances. Hormonal imbalances refer to the condition where there is either an excess or a deficiency of a hormone in the bloodstream. This can often happen due to stress, aging, certain medical conditions, or lifestyle decisions, which disrupt the typical production and regulation of hormones within the body. Synthetic hormones serve as a supplement or substitution for natural hormones during such imbalances, as they help to manage bodily functions and mitigate the symptoms linked with hormonal deficiencies or surpluses. For example, in 2022, the NHS Business Services Authority, a non-departmental public body in the UK, reported a prescription of approximately 7.80 million Hormone Replacement Therapy (HRT) items in England. This was a surge of about 35.0% compared with the previous year. As a result, the rising occurrence of hormonal imbalances is propelling the expansion of the synthetic hormones market.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=14515&type=smp

How Is the Synthetic Hormones Market Segmented by Several Divisions?

The synthetic hormones market covered in this report is segmented –

1) By Product Type: Steroid Hormones, Peptide Hormone, Amino Acid Derivatives, Other Product Types

2) By Route of Administration: Oral, Nasal, Topical, Intravenous

3) By Application: Growth Hormone Deficiency, Thyroid Hormone Deficiency, Menopause, Male Hypogonadism, Other Applications

4) By End User: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies

Subsegments:

1) By Steroid Hormones: Corticosteroids, Estrogens and Progesterone, Androgens, Progestins

2) By Peptide Hormones: Insulin, Growth Hormones, Thyroid Stimulating Hormones, Leptin

3) By Amino Acid Derivatives: Thyroxine (T4), Epinephrine (Adrenaline), Melatonin, Serotonin

4) By Other Product Types: Vitamin D Derivatives, Prostaglandins, Gonadotropins

What are the Emerging Market Trends Driving the Growth of the Synthetic Hormones Industry?

Key businesses in the synthetic hormone industry are situating themselves to increase their market shares by introducing novel products, for instance, the recombinant human growth hormone. This manufactured hormone is utilized for managing growth hormone deficiency in both children and adults and treating specific health issues linked with this deficiency. As an illustrative example, Pfizer Inc., an American pharmaceutical company, and OPKO Health Inc., also an American company specializing in medical testing and medication, gained marketing clearance in the European Union for NGENLA (somatrogon) injections administered once per week, as of February 2022. The approval is specifically for dealing with pediatric growth hormone deficiency in children and teens aged three years and above. It provides a viable option for those affected by growth irregularities that result from inadequate growth hormone production. As compared to the daily growth hormone injections, NGENLA, which is injected subcutaneously, remains effective within the body for a longer period; hence, it only requires weekly administration.

Access The Full Report Here:

https://www.thebusinessresearchcompany.com/report/synthetic-hormones-global-market-report

Which Regions Are Driving Growth in the Synthetic Hormones Market?

North America was the largest region in the synthetic hormones market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the synthetic hormones market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase The Full Report Today:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=14515

This Report Delivers Insight On:

1. How big is the synthetic hormones market, and how is it changing globally?

2. Who are the major companies in the synthetic hormones market, and how are they performing?

3. What are the key opportunities and risks in the synthetic hormones market right now?

4. Which products or customer segments are growing the most in the synthetic hormones market?

5. What factors are helping or slowing down the growth of the synthetic hormones market?

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 2071930708

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model